Wisconsin's energy future may include more biobased fuels to reduce the state's reliance on imported oil and reinvigorate rural economies. A recent policy initiative, consortium and related bill from Madison explore ethanol use and production expansion and try to incorporate major industrial sectors into the...
A recent patent law decision will render hundreds of pending patent applications worthless and will raise the bar for proving the usefulness of gene and protein related inventions....
Three UW-Madison scientists have invented a method of directing embryonic stem cells to turn into pancreatic islet cells, the Wisconsin Alumni Research Foundation (WARF) announced last week. The procedure has the potential to greatly increase the number of islet cells available for transplantation into...
Last week’s article focused on the performance of the Midwest Large Cap Life Science group of companies and the overall stock market for the first three quarters of 2005. Results for this period showed a recovery of the major indices during the third quarter from...
Research scientist Seth Dobrin, Ph.D., has been named the new head of the Center for Human Genetics' Mammalian Genotyping Service of the Marshfield Clinic Research Foundation....
The quality of Wisconsin stem cell research has been validated by the NIH, an agency that is always the first to complain if ethical guidelines are stretched. The goals of that research are supported by most citizens, according to all available polls. ...
Publicly traded Midwest companies involved in life sciences showed legs and life for the first nine months of 2005, with the biotech indices actually showing growth, meaning that the actual results during the third quarter were strong. ...
The WiCell Research Institute at UW-Madison has been selected by the National Institutes of Health (NIH) to establish the federal government's first and only National Stem Cell Bank (NSCB) -- a $16 million endeavor for UW....
Three Wisconsin businesses will receive funding for technology development projects from the state Department of Commerce Technology Assistance Grant (TAG) and Technology Venture Fund (TVF) Programs. ...
Third Wave Technologies Inc., a developer of molecular diagnostics for a variety of DNA and RNA analysis applications, is being sued by Belgium-based Innogenetics, N.V., which alleges infringement of its hepatitis C virus patents. Meanwhile, in a separate case, Third Wave has won a ruling...